Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits: a Randomized, Double-blind, Placebo-controlled Trial

NCT04419272 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04419272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04419272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits: a Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Recruiting
Start date
August 14, 2023
Completion date
May 31, 2028
Enrollment
226 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy